Curie.Bio co-founders Alexis Borisy (L) and Zach Weinberg
June 26, 2024 07:40 AM EDT
Financing
Startups

Alex­is Borisy and Zach Wein­berg's Curie.Bio se­cures $380M to sup­port port­fo­lio's Se­ries A rounds

Kyle LaHucik

Senior Reporter

Curie.Bio, a Cam­bridge, MA-based biotech ac­cel­er­a­tor that aims to “free the founders,” has raised a $380 mil­lion fund main­ly to sup­port nascent star­tups that grad­u­ate …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

A service from the Financial Times